Providence Saint Mary Regional Cancer Center — Walla Walla, Washington

Providence Saint Mary Regional Cancer Center is a clinical research site located in Walla Walla, Washington, United States 99362.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Providence Saint Mary Regional Cancer Center has participated in 224 clinical trials with 144 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Saint Mary Regional Cancer Center?

Providence Saint Mary Regional Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Saint Mary Regional Cancer Center conducted?

Providence Saint Mary Regional Cancer Center has 224 clinical trials on record, with 144 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is Providence Saint Mary Regional Cancer Center accredited by Crixeo Health?

Providence Saint Mary Regional Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Saint Mary Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.